Comparison of neoadjuvant adriamycin and docetaxel versus adriamycin, cyclophosphamide followed by paclitaxel in patients with operable breast cancer

PURPOSE: Neoadjuvant chemotherapy is the standard treatment for patients with locally advanced breast cancer and is increasingly considered for patients with operable disease. Recently, as many clinical trials have demonstrated favorable outcomes of anthracycline-taxane based regimen, this approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Woo Sung, Jeon, Ja Young, Kang, Seok Yun, Jung, Yong Sik, Kim, Ji Young, Ahn, Mi Sun, Kang, Doo Kyoung, Kim, Tae Hee, Yim, Hyun Ee, An, Young-Sil, Park, Rae Woong, Kim, Ku Sang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Surgical Society 2013
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699689/
https://www.ncbi.nlm.nih.gov/pubmed/23833754
http://dx.doi.org/10.4174/jkss.2013.85.1.7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3699689/
https://www.ncbi.nlm.nih.gov/pubmed/23833754
http://dx.doi.org/10.4174/jkss.2013.85.1.7

Ejemplares similares